SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ibon Eguíluz-Gracia, Teresa Robledo-Echarren, Ricardo Suárez-Fernández, Montserrat Fernández-Rivas, Silvia Sánchez-Ramón, Omalizumab for the treatment of atopic dermatitis, Clinical Investigation, 2015, 5, 2, 121

    CrossRef

  2. 2
    Haeyong Lee, Sungmin Bae, Jaewoong Jang, Byoung Whui Choi, Choon-Sik Park, Jong Sook Park, Seung-Hyo Lee, Yoosik Yoon, CD53, a suppressor of inflammatory cytokine production, is associated with population asthma risk via the functional promoter polymorphism −1560 C>T, Biochimica et Biophysica Acta (BBA) - General Subjects, 2013, 1830, 4, 3011

    CrossRef

  3. 3
    A. Lewis, J. Wan, B. Baothman, P. N. Monk, S. K. Suvarna, P. T. Peachell, Heterogeneity in the responses of human lung mast cells to stem cell factor, Clinical & Experimental Allergy, 2013, 43, 1
  4. 4
    K. Eyerich, N. Novak, Immunology of atopic eczema: overcoming the Th1/Th2 paradigm, Allergy, 2013, 68, 8
  5. 5
    Yoshie Yoshikawa, Yusuke Sasahara, Katsuyuki Takeuchi, Yoshimasa Tsujimoto, Takashi Hashida-Okado, Yukio Kitano, Tomoko Hashimoto-Tamaoki, Transcriptional Analysis of Hair Follicle-Derived Keratinocytes from Donors with Atopic Dermatitis Reveals Enhanced Induction of IL32 Gene by IFN-γ, International Journal of Molecular Sciences, 2013, 14, 2, 3215

    CrossRef

  6. 6
    Natalija Novak, An update on the role of human dendritic cells in patients with atopic dermatitis, Journal of Allergy and Clinical Immunology, 2012, 129, 4, 879

    CrossRef

  7. 7
    Th. Bieber, Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine, Allergy, 2012, 67, 12
  8. 8
    Natalija Novak, Donald YM Leung, Advances in atopic dermatitis, Current Opinion in Immunology, 2011, 23, 6, 778

    CrossRef